Cerevance
Cerevance is a clinical-stage biopharmaceutical company developing novel therapeutics for central nervous system (CNS) disorders. Its proprietary NETSseq platform profiles gene expression across specific human brain cell types from post-mortem tissue to identify previously undiscovered, cell-type-specific drug targets, powering a pipeline of small-molecule candidates for Parkinson's disease, Alzheimer's disease, epilepsy, and other neurodegenerative and psychiatric conditions. Surfaced as a portfolio company of GV; profiled in the API Evangelist network. Cerevance publishes no public API, developer portal, or SDK.
Cerevance is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Drug Discovery.
Cerevance’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API